Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch.
Tu WJ, McCuaig RD, Tan AHY, Hardy K, Seddiki N, Ali S, Dahlstrom JE, Bean EG, Dunn J, Forwood J, Tsimbalyuk S, Smith K, Yip D, Malik L, Prasanna T, Milburn P, Rao S.
Tu WJ, et al.
Front Immunol. 2020 Jun 16;11:1228. doi: 10.3389/fimmu.2020.01228. eCollection 2020.
Front Immunol. 2020.
PMID: 32612611
Free PMC article.